Literature DB >> 2784106

Expression of the p75 interleukin 2-binding protein on CD3+4-8-Tac- cells from autoimmune MRL/MP-lpr/lpr mice.

J C Gutierrez-Ramos1, L Pezzi, R Palacios, C Martínez.   

Abstract

The recently described (Sharon, M. et al., Science 1986. 234:859) interleukin 2 (IL 2)-binding molecule p75 was detected in the CD3+4-8-Tac- "double-negative" cell population selectively expanded in lupus-like autoimmune mice MRL/MP-lpr/lpr using cross-linking studies. Scatchard analysis of the IL 2 binding revealed the existence of approximately 4700 sites per cell with an apparent Kd of 1500 pM. The cell line LD1.T3B, derived from this population, shared surface markers and the p75 presence/p55 absence of IL 2-binding proteins with its in vivo counterpart, displaying around 3100 sites per cell with a Kd of about 1300 pM. Functional studies showed that high doses of IL 2 had an inhibitory effect on the autonomous growth of this cell line in the absence of the development of killer activity. This study provides evidence of the functional abilities of p75, and shows that the use of Tac/p55 surface expression only to evaluate IL 2 receptors and T cell activation can be an oversimplification as well as misleading.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784106     DOI: 10.1002/eji.1830190133

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

Review 1.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Lymphoid cells in afferent and efferent intestinal lymph: lymphocyte subpopulations and cell migration.

Authors:  H J Rothkötter; T Huber; N N Barman; R Pabst
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

3.  Interleukin 2 abrogates the nonresponsive state of T cells expressing a forbidden T cell receptor repertoire and induces autoimmune disease in neonatally thymectomized mice.

Authors:  J L Andreu-Sánchez; I M Moreno de Alborán; M A Marcos; A Sánchez-Movilla; C Martínez-A; G Kroemer
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.